IT-901 (IT901) is a novel, oral and potent c-Rel Inhibitor targeting the NF-κB subunit of c-Rel with anticancer effects. It has the potential for treating human lymphoid tumors and ameliorate graft-versus-host disease (GVHD).

纯度：≥98%

CAS：1584121-99-2